Latest News
- Freight Surge and Gulf Tensions Threaten India’s Pharma Exports; Industry Flags Potential ?5,000-Crore Impact
- India Scales Up HPV Vaccination, Screening in Cervical Cancer Elimination Push: Health Minister J.P. Nadda
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
Thermo Fisher Scientific Expands Bengaluru R&D Centre with Rs 160 Crore Investment, Pledges 100 New Jobs
With this expansion, Thermo Fisher plans to create over 100 new jobs, adding to its existing 1,400-plus professionals in Bengaluru, further deepening its presence and investment in India’s life sciences landscape.
- By Newsdesk
- Bengaluru
- Oct 28, 2025
Global life-science leader Thermo Fisher Scientific has announced an investment of ₹160 crore to expand its Bengaluru Research & Development Centre of Excellence, reinforcing its long-term commitment to India’s innovation ecosystem.
Spanning approximately 37,000 square feet, the expanded facility will feature advanced automation and analytical platforms focused on antibody design, development, and manufacturing strengthening Thermo Fisher’s capabilities in life sciences research and diagnostics.
Karnataka’s Minister for Electronics, IT & BT and Rural Development & Panchayat Raj, Priyank Kharge, lauded the development, stating that it reinforces Karnataka’s position as a leading biotechnology and life-sciences hub driven by collaboration among government, academia, and industry.
For Thermo Fisher, Bengaluru remains a strategic innovation hub. Gianluca Pettiti, Executive VP and Sector President for Life Sciences, Diagnostics & Applied Markets, said the investment aims to accelerate scientific breakthroughs and enhance service to both Indian and global customers.
Since its inception 18 years ago, the Bengaluru centre has developed more than 2,000 recombinant antibodies, validated over 25,000 antibodies through its testing programmes, and produced over 2,000 primary and secondary antibodies for researchers worldwide.
The move aligns with Karnataka’s vision of becoming a preferred destination for advanced R&D and manufacturing. The state contributes over 10 % of India’s pharmaceutical revenue and nearly 60 % of its biotechnology revenue, with a bio-economy valued at around USD 31 billion.
With this expansion, Thermo Fisher plans to create over 100 new jobs, adding to its existing 1,400-plus professionals in Bengaluru, further deepening its presence and investment in India’s life sciences landscape.